Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [14C]Xevinapant, a Potent, Oral, Small-Molecule IAP Inhibitor.

xevinapant (Debio 1143) - EMD Serono

http://www.ncbi.nlm.nih.gov/pubmed/41784079

Annick Menetrey; Felix Rohdich; Holger Scheible; Karthik Venkatakrishnan; Marie-Claude Roubaudi-Fraschini; Tri Tat; Valérie Nicolas-Métral; Yuan Zhao; Yulia Vugmeyster

Mar 5, 2026